MINI FUTURE OPTIONSSCHEIN PUT - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 20:34:36 06/06/2024 BST | ||
| 30.7 EUR | -0.90% |
|
| Current month | -6.16% | ||
| 1 month | -18.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 30.76 | -0.71% |
| 05/06/24 | 30.98 | -0.39% |
| 04/06/24 | 31.1 | -0.16% |
| 03/06/24 | 31.15 | -4.97% |
| 31/05/24 | 32.78 | -0.52% |
Real-time Boerse Frankfurt Warrants
Last update June 06, 2024 at 08:34 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | DZ BANK |
| WKN | DQ09EU |
| ISIN | DE000DQ09EU6 |
| Date issued | 06/03/2024 |
| Strike | 1,170 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 34.42 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 41.91 € |
|---|---|
| Lowest since issue | 30 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
837.3
USD
Average target price
853.8
USD
Spread / Average Target
+1.97%
- Stock Market
- Certificates
- Certificat